The last day of June 2017 saw the Supreme Court of Canada (SCC) quash the controversial Promise Doctrine. The issue at hand in AstraZeneca Canada Inc v Apotex Inc was…
Category: Commercialization
in Canada, Canadian Telecom Summit 2017, Commercialization, Feature Post, Innovation, IP, IP Reform, Technology, Telecommunications0by Editor
1378
Connecting Canadians, Empowering Inclusive Innovation
Innovation is, once again, a topic of great concern for Canadian policy makers and the commentariat. And for good reason. Yet, at a time when (mainly foreign) companies – notably…
in Access to Medicines, Commercialization, Design, Development, IP, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
2385
What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work
This past November, Professor Ronald E. Pearlman from York University’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR…
in Commercialization, Copyright, Gaming, Internet Sharing, IP, Movies, Smartphones, Technology0by Editor
1608
The Price for Pokemon - How Much Are Childhood Icons Worth Protecting?
The Value of the Pokémon Franchise If you were born in the late 1980s or early 90s or have young children, you have probably encountered a red-cheeked mouse called Pikachu…
More Money, More Problems: The Science, the Law, and the Fight over CRISPR Patents
From Lab Bench to Court Bench: The Science, the Law, and the CRISPR Patent Dispute Whenever a new technology has the potential to be ground-breaking and extremely valuable, there are…
Do War Criminals Have Copyrights? The Role of Morality in Controversial Works
At first, a request for royalties by the estate of Nazi propagandist Goebbels was considered a joke by counsel for Random House. But the publisher now finds itself in the middle of a…